HSDT - Helius Medical Technologies Inc. to Present at the 36th Annual ROTH Conference | Benzinga
NEWTOWN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the 36th Annual ROTH Conference, March 17-19, 2024, Laguna Nigel, CA, as follows:
| Date: |
| Monday, March 18, 2024 |
| Time: |
| 1:30pm PT |
| Webcast: |
| Click here |
Investors and attendees who would like to schedule a 1-on-1 meeting with Helius management are asked to contact their Roth Capital representative.
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies ...